Literature DB >> 14574973

Amniotic membrane transplantation for conjunctival tumor.

Zhicong Chen1, Jianhua Yan, Huasheng Yang, Zhongyao Wu, Youjian Pang, Shiming Ai, Yuxiang Mao.   

Abstract

PURPOSE: To evaluate the possibility of amniotic membrane transplantation (AMT) for the treatment of conjunctival tumor.
METHODS: Preserved AMT was performed in 26 patients (26 eyes) with conjunctival tumor, including 9 eyes (34.62%) with malignant tumor (conjunctival malignant melanoma, corneal and conjunctival squamous cell carcinoma, conjunctival lymphoma), 17 eyes (65.38%) with benign tumor (conjunctival papilloma, conjunctival dermoid tumor, conjunctival nevus, hemangioma etc.). RESULT: All the patients are followed up for 1-53 months. No acute rejection was observed after preserved AMT. Ideal healing was found in conjunctiva wound.
CONCLUSION: Preserved AMT is a very effective method to repair wound after giant conjunctival tumor operation. Complete removal of tumor and perfect fixation are the key of ocular surface reconstruction.

Entities:  

Mesh:

Year:  2003        PMID: 14574973

Source DB:  PubMed          Journal:  Yan Ke Xue Bao        ISSN: 1000-4432


  4 in total

1.  [Squamous cell carcinoma of the conjunctiva with orbital invasion: orbital exenteration or minimally invasive procedure?].

Authors:  J Beutel; K Sommer; S Gottschalk; B Neppert; G Geerling
Journal:  Ophthalmologe       Date:  2006-08       Impact factor: 1.059

2.  Update on amniotic membrane transplantation.

Authors:  Jingbo Liu; Hosam Sheha; Yao Fu; Lingyi Liang; Scheffer Cg Tseng
Journal:  Expert Rev Ophthalmol       Date:  2010-10

3.  Fibrin-glue assisted multilayered amniotic membrane transplantation in surgical management of pediatric corneal limbal dermoid: a novel approach.

Authors:  Amir Pirouzian; Hang Ly; Huck Holz; Rattehalli S Sudesh; Roy S Chuck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-07       Impact factor: 3.117

4.  Management of pediatric corneal limbal dermoids.

Authors:  Amir Pirouzian
Journal:  Clin Ophthalmol       Date:  2013-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.